Similarly, concentrations of CCL3, CCL4, CCL20, CXCL8, and CXCL10 in the NASH group (SMDs of 0.90, 2.05, 2.16, 0.91, and 1.46, respectively) were significantly higher than that in the control group (Table 1B). This evidence concerns the gene CXCL10 and metabolic dysfunction-associated steatohepatitis.